Press Review

Young researchers for a day at Sissa in Trieste
ArcyNewsy

How can you find out what’s inside a sealed box that can’t be opened? [...] Tomorrow the children of a sixth grade school in Trieste will try their hand at these and other questions at Sissa University, the International School of Advanced Studies, on the occasion of the first national University Day, an event promoted by the Conference of Italian Rectors (Crui).

Read the article here.

Un'italiana direttrice scientifica dell'azienda biotech Egle: ha studiato alla SISSA!
Trieste cafe

La ricercatrice italiana Monica Gostissa è il nuovo direttore scientifico della Egle Therapeutics, azienda biotecnologica specializzata in terapie innovative sui linfociti T per il trattamento di tumori e malattie autoimmuni. [...] Gostissa ha conseguito il dottorato in Genetica molecolare alla Scuola Internazionale Superiore di Studi Avanzati di TRIESTE

Leggi l'articolo qui.

"Savona, La Riviera E L'entroterra", l'ultimo libro di Ilaria Caprioglio e Doriana Rodino
Eco di Savona

E' arrivato in tutte le librerie e negli store online la guida "Savona, la Riviera e l'entroterra" di Ilaria Caprioglio e Doriana Rodino [...]. Doriana Rodino dal 2018 al 2021 è stata assessore a Cultura, Musei, Promozione turistica, Campus universitario, Politiche giovanili e Pari Opportunità per il Comune di Savona. Editor e docente per Alpha Test, è dottore di ricerca in Biologia e si è specializzata in Comunicazione della Scienza alla SISSA di Trieste.

Leggi l?articolo qui.

Scienza e Virgola 2024, 8^ edizione ?
Freaksonline

Scienza e Virgola, il Science and Media Festival organizzato dal Laboratorio Interdisciplinare della SISSA, torna a Trieste dal 16 al 21 maggio 2024 con la sua 8^ edizione.

Leggi l'articolo qui.

SMACT fa incontrare ricerca e impresa
Veneto Economy - Opportunità di business

SMACT, il Centro di Competenza Industria 4.0, offre consulenza e formazione alle aziende che vogliono aumentare il proprio potenziale innovativo SMACT è uno degli otto Centri di Competenza Industria 4.0 nati per favorire l'incontro tra ricerca e impresa. I soci fondatori di SMACT sono 8 università del Triveneto (Padova, Verona, Ca' Foscari, IUAV, Trento, Bolzano, Udine e SISSA di Trieste).

Leggi l'articolo qui.

Da Riva Ligure si svelano i misteri della biologia: il comunicatore scientifico Gioele Lecquio pubblica un nuovo libro (foto)
Sanremo News

L'opera è stata scritta insieme ad Alessandra Ria [...]. Alessandra Ria è laureata in Molecular Biology and Genetics all'Università di Pavia, si successivamente specializzata in comunicazione della scienza presso la SISSA di Trieste.

Leggi l'articolo qui.

La speranza di un rene
Raiplaysound

Si chiama Richard Slayman, ha 62 anni, ed è il primo essere umano vivente al mondo ad aver ricevuto un rene di maiale geneticamente modificato. [...] E quali sono gli aspetti bioetici da tener presente quando si effettua uno xenotrapianto e se questa tecnica diventerà una pratica abituale? Rispondono Emanuele Cozzi, [...] e Mariachiara Tallacchini, docente di scienza, diritto e democrazia alla Scuola Internazionale di Studi Superiori Avanzati (SISSA) di Trieste.

Leggi l'articolo qui.

Egle Therapeutics Appoints Monica Gostissa as CSO and Reno Winter as CTO
First World Pharma

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Pharmaceutical daily

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Yahoo! Finance

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Diversità nella scienza, parità di genere a Scienza e virgola
ANSA
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Morningstar.com

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
The Valdosta Daily Times

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Business.malvern-online.com

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Maryville Forum

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
The Community Post

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Bluefield Daily Telegraph

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Livermore

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Starkville Daily News

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Benzinga

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.